Theseus Pharmaceuticals (NASDAQ:THRX) PT Lowered to $7.00
Theseus Pharmaceuticals (NASDAQ:THRX – Get Free Report) had its target price cut by analysts at Wedbush from $24.00 to $7.00 in a research report issued to clients and…
Read more Theseus Pharmaceuticals (NASDAQ:THRX) PT Lowered to $7.00